Literature DB >> 9150465

Cyclic ADP-ribose metabolism in rat kidney: high capacity for synthesis in glomeruli.

E N Chini1, P Klener, K W Beers, C C Chini, J P Grande, T P Dousa.   

Abstract

Recent discovery of cyclic ADP-ribose (cADPR) as an agent that triggers Ca2+ release from intracellular stores, through ryanodine receptor channel, is an important new development in the investigation of intracellular signaling mechanisms. We determined the capacity of kidney and its components for synthesis of cADPR from beta-NAD, that is catalyzed by enzyme ADP-ribosyl cyclase, and enzymatic inactivation that is catalyzed by cADPR-glycohydrolase. Little or no activity of ADP-ribosyl cyclase was found in extracts from the whole rat kidney, renal cortex, outer and inner medulla. On the other hand, incubation of beta-NAD with similar extracts from rat liver, spleen, heart, and brain resulted in biosynthesis of cADPR. In addition, extracts from suspension of proximal tubules or microdissected proximal convoluted tubules virtually lacked ADP-ribosyl cyclase activity. In sharp contrast to proximal tubules and cortex, extracts from glomeruli had high ADP-ribosyl cyclase activity, similar to that found in non-renal tissues. Authenticity of cADPR biosynthesized in glomeruli was documented by several criteria such as HPLC analysis, effect of inhibitors and homologous desensitization of Ca(2+)-release bioassay. On the other hand, the activity of cADPR-glycohydrolase was similar in extracts from glomeruli and in extracts from kidney cortex. Mesangial cells and vascular smooth muscle cells grown in primary culture displayed considerable ADPR-ribose cyclase activity. Our results show that extracts from glomeruli, unlike extracts from renal tissue zones and proximal tubules, have a singularly high capacity for synthesis of cADPR. We surmise that cADPR-triggered Ca(2+)-releasing system can serve as an intracellular signaling pathway that may be operant in regulations of glomerular cell functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150465     DOI: 10.1038/ki.1997.206

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Effect of estrogen upon cyclic ADP ribose metabolism: beta-estradiol stimulates ADP ribosyl cyclase in rat uterus.

Authors:  E N Chini; F G de Toledo; M A Thompson; T P Dousa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

2.  New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing.

Authors:  Ondrej Lisy; John C Burnett
Journal:  Circulation       Date:  2006-01-09       Impact factor: 29.690

3.  Nicotinic acid-adenine dinucleotide phosphate (NAADP) elicits specific microsomal Ca2+ release from mammalian cells.

Authors:  A N Yusufi; J Cheng; M A Thompson; E N Chini; J P Grande
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

4.  Transformation and action of extracellular NAD+ in perfused rat and mouse livers.

Authors:  Ana Carla Broetto-Biazon; Fabrício Bracht; Livia Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

Review 5.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.